Review of Isolated Hypoganglionosis and Presentation of a New Case Complicated With Sigmoid Volvulus
Systematic Review of Isolated Hypoganglionosis and Presentation of a New Case Complicated With Sigmoid Volvulus
1 other identifier
observational
310
1 country
1
Brief Summary
Isolated hypoganglionosis is rare and constitutes 3-5% of all congenital neurological bowel diseases. Since hypoganglionosis is associated with symptoms such as chronic constipation or pseudo-obstruction, it can be confused with Hirschprung's disease and it is important to make a differential diagnosis before treatment. Our aim in this study; In addition to sharing the rarely isolated hypoganglionosis and sigmoid volvulus in a 45-year-old male patient with mental retardation, the investigators present a systematic comprehensive review of hypoganglionosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 20, 2020
CompletedFirst Submitted
Initial submission to the registry
April 23, 2020
CompletedFirst Posted
Study publicly available on registry
April 27, 2020
CompletedApril 28, 2020
April 1, 2020
1.2 years
April 23, 2020
April 26, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mortality
Mortality of sigmoid volvulus due to isolated hypoganglionosis
three months
Interventions
Pathology result of rectal biopsy
Eligibility Criteria
our case of isolated hypoganglionosis and published isolated hypoganglionosis studies patients.
You may qualify if:
- isolated hypoganglionosis
- our case of isolated hypoganglionosis
You may not qualify if:
- hypoganglionosis with Hirschsprung's disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Dr. Ersin Arslan Education and Training Hospitallead
- Inonu Universitycollaborator
Study Sites (1)
Dr. Ersin Arslan Training and Resource Hospital
Gaziantep, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
ufuk uylas, Specialist
Dr. Ersin Arslan Training and Resource Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- OTHER
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 23, 2020
First Posted
April 27, 2020
Study Start
January 1, 2019
Primary Completion
April 1, 2020
Study Completion
April 20, 2020
Last Updated
April 28, 2020
Record last verified: 2020-04